# IVD 510(k) outline completion

F1, W1/D2; P-114 item 5. Starting canonical source: `3692f44adc02ba891ae7e6876a990ad5f8d31740`. Design: `.design/client-journey/IVD_510K_OUTLINE_COMPLETION_2026-11-14.md`.

## What already exists

The existing US IVD blueprint in `shared/regulatory/project-bootstrap.ts` shares EU performance-evaluation content. The existing generic FDA pack has no analytical-performance node. `rule-pack-lookup.ts`, `scaffold-project-documents.ts`, project creation and `vault-folders.ts` own outline selection and binding. `estar-mapper.ts` and `estar-outline-requirements.ts` own requirements, and the vendored FDA IVD PDF owns the form structure. `document-template-library.ts` serves the existing blueprint into the editor. Complete those owners; preserve retained document versions and the existing variant-aware eSTAR UI.

Live/deleted searches and scope are recorded in the linked design. Initial deleted-history search is bounded by a shallow clone; no exhaustive historical absence is claimed. D8 CSS and W7's held host/drawer files are excluded.

## Current status

Implemented in the existing owners. The approved IVD content version has 47 stable keys; new IVD/CDx projects select it explicitly, while non-IVD projects and retained documents keep their existing versions. The US template no longer serves EU IVDR citations. Analytical performance has its own required section; mandatory biocompatibility review remains enforced. Bench/animal headings retain their prior meanings without becoming blanket study obligations.

Latest unique automated qualification: **829 passed across 31 files; zero failed or pending** (`current-test-matrix.json`). This includes actual PGlite SQL, three old/new migration replays, corruption refusal, real governed scaffold/audit, retained content, Vault projection, template-to-mapper coverage and existing client filing controls. Forced lint: 0 errors; 9 existing warnings, with unchanged per-file counts.

The combined runtime inputs stayed unchanged. One test-only describe grouping changed during that run; its exact reversible bridge and a fresh whole 13-case file replace that row. Test bodies and assertions are byte-identical. Original RED and intermediate candidate receipts are retained. The 45-node/no-branch inventory and unchecked BIO candidate are explicitly superseded by raw XFA/script inspection and the final required-review contract. The initial selection RED contains eight genuine selector failures and one invalid fixture view (`mdx` instead of `ivd`), corrected before the successful cohort.

Build, full compiler and normal canonical publication are pending. No screen or styling changes were made. No human, agency, deployment or native PostgreSQL claim is made. No device transmission is promised.
